Insulin treatment of streptozotocin-induced diabetes re-establishes the patterns in carbohydrate, fat and amino acid metabolisms in growing pigs

Laboratory Animals

Volumn 48, Issue 3, 2014, Pages 261-269

  Manell, E A K ^a   Ryden A ^a   Hedenqvist, P ^a   Jacobson, M ^a   Jensen Waern, M ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Alanine; Branched chain amino acids; Insulin therapy; Swine; Triglycerides

Indexed keywords

ALANINE; BRANCHED CHAIN AMINO ACID; C PEPTIDE; CARBOHYDRATE; FATTY ACID; GLUCOSE; MEDETOMIDINE; SHORT ACTING INSULIN; STREPTOZOCIN; TAURINE; TRIACYLGLYCEROL;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DRUG DOSE INCREASE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; LIPID METABOLISM; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; YORKSHIRE PIG;

ANIMALIA; SUIDAE;

EID: 84906051356     PISSN: 00236772     EISSN: 17581117     Source Type: Journal    
DOI: 10.1177/0023677213517683     Document Type: Article

References (34)

1. Larsen MO and Rolin B. Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 2004; 45: 303–313.
2. Biester HE. Diabetes in a pig showing pancreatic lesions. J Am Vet Med Assoc 1925; 67: 99–109.
3. Yamamato H, Uchigata Y and Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 1981; 294: 284–286.
4. Elsner M, Gludbakke B, Tiedge M, Munday R and Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologica 2000; 43: 1528–1533.
5. Gäbel H, Bitter-Suermann H, Henriksson C, Säve- Sö derberg J, Lundholm K and Brynger H. Streptozotocin diabetes in juvenile pigs. Evaluation of an experimental model. Horm Metab Res 1985; 17: 275–280.
6. Jensen-Waern M, Andersson M, Kruse R, et al. Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism. Lab Anim 2009; 43: 249–254.
7. MacLeod JJR. Insulin and diabetes: a general statement of the physiological and therapeutic effects of insulin. Br Med J 1922; 4: 833–835.
8. Felig P, Pozefsky T, Marliss E and Cahill GF. Alanine: key role in gluconeogenesis. Science 1970; 167: 1003–1004.
9. Blackshear PJ and Alberti KGMM. Sequential amino acid measurements during experimental diabetic ketoacidosis. 1975; 228: 205–211.
10. Rodríguez T, Alvarez B, Busquets S, Carbó N, Ló pez-Soriano FJ and Argilés JM. The increased skeletal muscle proteitturnover of the streptozotocin diabetic rat is associated with high concentrations of branched-chain amino acids. Biochem Mol Med 1997; 61: 87–94.
11. Staehr P, Hother-Nielsen O, Landau BR, Chandramouli V, Holst JJ and Beck-Nielsen H. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 2003; 52: 260–267.
12. Zmyslowska A, Wyka K, Szadkowska A, Mianowska B, Pietrzak I and Mlynarski W. Free fatty acids level may effect a residual insulin secretion in type 1 diabetes. Pediatr Endocrinol Diabetes Metab 2011; 17: 26–29.
13. Nilsson Nö, Stralfors P, Fredriksson G and Belfrage P. Regulation of adipose tissue lipolysis effects of noradrenaline and insulin on phosphorylation of hormone-sensitive lipase and on lipolysis in intact rat adipocytes. FEBS Lett 1980; 111: 125–130.
14. Albrink MJ and Man EB. Serum triglycerides in health and diabetes. Diabetes 1958; 7: 194–201.
15. Lopes-Virella MF, Wohltmann HJ, Loadholt CB and Buse MG. Plasma lipids and lipoproteins in young insulin- dependent diabetic patients: relationship with control. Diabetologica 1981; 21: 216–223.
16. Bagdade JD, Porte D and Bierman EL. Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes 1968; 17: 127–132.
17. Hara H, Lin YJ, Zhu X, et al. Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas 2008; 36: 31–38.
18. Wallgren P and Vallgarda J. SPF pigs – presentation, definition and specification of regulations. Swed Vet J 1993; 45: 733–735.
19. Göransson L and Lindberg JE. Nutrition recommendations for growing pigs. Uppsala: Swedish Univerity of Agricultural Science, 2011.
20. Jacobsson M, Har af Segerstad C, Gunnarsson A, et al. Diarrhoea in the growing pig – a comparison of clinical, morphological and microbial findings between animals from good and poor performance herds. Res Vet Sci 2003; 72: 163–169.
21. Jonasson R, Essén-Gustavsson B and Jensen-Waern M. Blood concentrations of amino acids, glucose and lactate during experimental swine dysentery. Res Vet Sci 2007; 82: 323–331.
22. Pfeifer R, Karol R, Korpi J, Burgoyne R and McCourt D. Practical application of HPLC to amino acid analysis. Am Lab 1983; 15: 77–84.
23. Grossman EJ, Lee DD, Tao J, et al. Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin- induced diabetic mice. PloS One 2010; 18: e8749.
24. Hagen JH. Effect of glucagon on the metabolism of adipose tissue. J Biol Chem 1961; 236: 1023–1027.
25. Menahan LA and Wieland O. Interaction of glucagon and insulin on the metabolism of perfused livers from fasted rats. Eur J Biochem 1969; 9: 55–62.
26. Heimberg M, Weinstein I and Kohout M. The effects of glucagon, dibutyryl cyclic adenosine 3’,5’-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. J Biol Chem 1969; 244: 5131–5139.
27. Laurell S. Plasma free fatty acids in diabetic acidosis and starvation. Scand J Clin Lab Invest 1956; 8: 81–82.
28. Kudo H. Serum triglyceride levels of normal subjects. Tohoku J Exp Med 1969; 97: 35–46.
29. Munkner C. Fasting concentrations of non-esterified fatty acids in diabetic and non-diabetic plasma and diurnal variations in normal subjects. Scand J Clin Lab Invest 1959; 11: 388–393.
30. Heald FP, Arnold G, Seabold W and Morrison D. Plasma levels of free fatty acids in adolescents. Am J Clin Nutr 1967; 20: 1010–1014.
31. Bronte V, Serafini P, Mazzoni A, Segal DM and Zanovello P. L-arginine metabolism in myeloid cells controls T-lymfocyte functions. Trends Immunol 2003; 24: 302–306.
32. Franconi F, Bennardini F, Mattana A, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 1995; 61: 1115–1119.
33. Hansen SH. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 2001; 17: 330–346.
34. Ito T, Schaffer SW and Azuma J. The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 2012; 42: 1529–1539.